Moreover, another research shown that altered miR-29a expression in intestine may regulate intestinal permeability in IBS patients through glutamine dependent mechanisms as proved by the functional interaction between miR-29a and the GLUL [25]. The gene discussed is GLUL; the disease is irritable bowel syndrome.